Search Results 2431-2440 of 16377 for Chronic Lymphocytic Leukemia

  1. Congenital Disorders Clinical Trials - Mayo Clinic Research

    ... diagnosis if available, demographic information, and to develop a biobank of DNA and white blood cell samples from infants with imperforate anus. If ...

  2. Prematurity Awareness Month: Mayo Clinic Expert Explains Risk Factors

    Some chronic conditions, such as asthma and diabetes. ... Lymphatic System. Related Articles. News Releases ... Hourglass-shaped stent could ease severe chest pain ...

  3. Clinical Core Laboratory Services - Laboratory Medicine and Pathology - Mayo Clinic

    The lab provides clinical testing in the areas of general chemistry, immunoassay, coagulation, hematology, renal and cardiovascular to aid in the diagnosis and ...

  4. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    Phase 4 trials look at long-term safety and ... histochemical diagnosis based on detection by ... Subject has plasma cell leukemia (> 2.0*10^9 /L ...

  5. How specialized blood cells could transform treatments for inflammatory disease - Mayo Clinic News Network

    If so, they want to know if this could offer a new therapeutic option for chronic inflammation that does not respond to standard treatment. William Faubion ...

  6. Crohn's Disease Clinical Trials

    ... severe ileocolic Crohn's disease who may benefit from treatment with ... chronic bowel disease that causes severe inflammation of the digestive tract.

  7. Klippel-Trenaunay syndrome - Doctors and departments - Mayo Clinic

    ... Lymphatic massage, Musculoskeletal exam, Physical ... Mayo Clinic doctors and researchers study causes, diagnosis and treatment options in vascular malformations, ...

  8. Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough - Mayo Clinic

    Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough · Share · Facebook · Twitter.

  9. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... diagnosis of unresectable or metastatic melanoma and experienced unequivocal progressive disease during treatment with a BRAF inhibitor if BRAF V600 ...

  10. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    The study will be monitored by an independent data and safety monitoring board. A long-term extension study will be available for patients completing the study.